ClinicalTrials.govpublic full text
A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)
myelodysplastic syndromes, secondary acute myeloid leukemia (aml), previously treated mds, oral clofarabine, intermediate-1, intermediate-2 and high risk mds, secondary aml (with history of mds), interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 826379
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.